142 related articles for article (PubMed ID: 19589203)
1. Adenovirus mediated transfer of p53, GM-CSF and B7-1 suppresses growth and enhances immunogenicity of glioma cells.
Pan D; Wei X; Liu M; Feng S; Tian X; Feng X; Zhang X
Neurol Res; 2010 Jun; 32(5):502-9. PubMed ID: 19589203
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for human nasopharyngeal carcinoma by adenovirus-mediated transfer of human p53, GM-CSF, and B7-1 genes in a mouse xenograft tumor model.
Ren SP; Wang L; Wang H; Wu B; Han Y; Wang LS; Wu CT
Cancer Biother Radiopharm; 2008 Oct; 23(5):591-602. PubMed ID: 18999931
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral-mediated transfer of human wild-type p53, GM-CSF and B7-1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro.
Ren SP; Wu CT; Huang WR; Lu ZZ; Jia XX; Wang L; Lao MF; Wang LS
Cancer Immunol Immunother; 2006 Apr; 55(4):375-85. PubMed ID: 16001164
[TBL] [Abstract][Full Text] [Related]
4. Recombinant adenoviral vector expressing human wild-type p53, GM-CSF, and B7-1 genes suppresses the growth of glioma in vivo.
Feng S; Han S; Pan D; Liu M; Feng X; Dong T; Li W; Wei X
Tumour Biol; 2014 May; 35(5):4411-7. PubMed ID: 24408016
[TBL] [Abstract][Full Text] [Related]
5. [Adenovirus-mediated transfer of human wild-type p53, GM-CSF, and B7-1 genes efficiently produces growth suppression and apoptosis of hepatocellular cells in vitro].
Shi M; Wang F; Liu M; Zhang B; Qiu Z; Lei Z; Masayoshi N; Gao L; Wu Z
Zhonghua Gan Zang Bing Za Zhi; 2001 Aug; 9(4):229-31. PubMed ID: 11602056
[TBL] [Abstract][Full Text] [Related]
6. Human autologous in vitro models of glioma immunogene therapy using B7-2, GM-CSF, and IL12.
Parney IF; Farr-Jones MA; Kane K; Chang LJ; Petruk KC
Can J Neurol Sci; 2002 Aug; 29(3):267-75. PubMed ID: 12195617
[TBL] [Abstract][Full Text] [Related]
7. Co-transfer of human wild-type p53 and granulocyte-macrophage colony-stimulating factor genes via recombinant adenovirus induces apoptosis and enhances immunogenicity in laryngeal cancer cells.
Qiu Z; Lao M; Wu C
Cancer Lett; 2001 Jun; 167(1):25-32. PubMed ID: 11323095
[TBL] [Abstract][Full Text] [Related]
8. Synergetic anticancer effect of combined quercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells in vitro.
Shi M; Wang FS; Wu ZZ
World J Gastroenterol; 2003 Jan; 9(1):73-8. PubMed ID: 12508355
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model.
Parney IF; Petruk KC; Zhang C; Farr-Jones M; Sykes DB; Chang LJ
Hum Gene Ther; 1997 Jun; 8(9):1073-85. PubMed ID: 9189765
[TBL] [Abstract][Full Text] [Related]
10. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
[TBL] [Abstract][Full Text] [Related]
11. Growth suppression and immunogenicity enhancement of Hep-2 or primary laryngeal cancer cells by adenovirus-mediated co-transfer of human wild-type p53, granulocyte-macrophage colony-stimulating factor and B7-1 genes.
Qiu ZH; Wu CT; Lao MF; Pan LZ; Li YM
Cancer Lett; 2002 Aug; 182(2):147-54. PubMed ID: 12048160
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
Shono T; Tofilon PJ; Schaefer TS; Parikh D; Liu TJ; Lang FF
Cancer Res; 2002 Feb; 62(4):1069-76. PubMed ID: 11861384
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
14. Combined radiation and p53 gene therapy of malignant glioma cells.
Badie B; Goh CS; Klaver J; Herweijer H; Boothman DA
Cancer Gene Ther; 1999; 6(2):155-62. PubMed ID: 10195882
[TBL] [Abstract][Full Text] [Related]
15. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
[TBL] [Abstract][Full Text] [Related]
16. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
[TBL] [Abstract][Full Text] [Related]
17. Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.
Herrlinger U; Jacobs A; Quinones A; Woiciechowsky C; Sena-Esteves M; Rainov NG; Fraefel C; Breakefield XO
Hum Gene Ther; 2000 Jul; 11(10):1429-38. PubMed ID: 10910140
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas.
Revoltella RP; Menicagli M; Campani D
Cytokine; 2012 Mar; 57(3):347-59. PubMed ID: 22200506
[TBL] [Abstract][Full Text] [Related]
19. Human brain tumor cell culture characterization after immunostimulatory gene transfer.
Parney IF; Farr-Jones MA; Koshal A; Chang LJ; Petruk KC
Neurosurgery; 2002 May; 50(5):1094-102. PubMed ID: 11950413
[TBL] [Abstract][Full Text] [Related]
20. Transduction of acute myeloid leukemia cells with third generation self-inactivating lentiviral vectors expressing CD80 and GM-CSF: effects on proliferation, differentiation, and stimulation of allogeneic and autologous anti-leukemia immune responses.
Koya RC; Kasahara N; Pullarkat V; Levine AM; Stripecke R
Leukemia; 2002 Sep; 16(9):1645-54. PubMed ID: 12200676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
